128 related articles for article (PubMed ID: 32452364)
1. [MALT1 in glioblastoma: the Flowers of Evil].
Maghe C; Jacobs KA; Bidère N; Gavard J
Med Sci (Paris); 2020 May; 36(5):452-454. PubMed ID: 32452364
[No Abstract] [Full Text] [Related]
2. Paracaspase MALT1 regulates glioma cell survival by controlling endo-lysosome homeostasis.
Jacobs KA; André-Grégoire G; Maghe C; Thys A; Li Y; Harford-Wright E; Trillet K; Douanne T; Alves Nicolau C; Frénel JS; Bidère N; Gavard J
EMBO J; 2020 Jan; 39(1):e102030. PubMed ID: 31774199
[TBL] [Abstract][Full Text] [Related]
3. [The stem cell niche in glioblastoma: from fundamental aspects to targeted therapies].
Turpin A; Sharif A; Stoven L; Blond S; Maurage CA; Le Rhun É
Bull Cancer; 2015 Jan; 102(1):24-33. PubMed ID: 25609493
[TBL] [Abstract][Full Text] [Related]
4. Understanding the role of tumor stem cells in glioblastoma multiforme: a review article.
Fatoo A; Nanaszko MJ; Allen BB; Mok CL; Bukanova EN; Beyene R; Moliterno JA; Boockvar JA
J Neurooncol; 2011 Jul; 103(3):397-408. PubMed ID: 20853017
[TBL] [Abstract][Full Text] [Related]
5. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma Stem Cells: Driving Resilience through Chaos.
Prager BC; Bhargava S; Mahadev V; Hubert CG; Rich JN
Trends Cancer; 2020 Mar; 6(3):223-235. PubMed ID: 32101725
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progression.
Lu IN; Dobersalske C; Rauschenbach L; Teuber-Hanselmann S; Steinbach A; Ullrich V; Prasad S; Blau T; Kebir S; Siveke JT; Becker JC; Sure U; Glas M; Scheffler B; Cima I
Nat Commun; 2021 Jun; 12(1):3895. PubMed ID: 34162860
[TBL] [Abstract][Full Text] [Related]
8. Pivotal Role of STAT3 in Shaping Glioblastoma Immune Microenvironment.
Piperi C; Papavassiliou KA; Papavassiliou AG
Cells; 2019 Nov; 8(11):. PubMed ID: 31698775
[TBL] [Abstract][Full Text] [Related]
9. The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
Koyama-Nasu R; Haruta R; Nasu-Nishimura Y; Taniue K; Katou Y; Shirahige K; Todo T; Ino Y; Mukasa A; Saito N; Matsui M; Takahashi R; Hoshino-Okubo A; Sugano H; Manabe E; Funato K; Akiyama T
Oncogene; 2014 Apr; 33(17):2236-44. PubMed ID: 23686309
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic endothelial-like cells in the glioblastoma tumor niche drive metabolic alterations that promote stem cell proliferation and survival.
Kidwell RL; Aghi MK
Neuro Oncol; 2024 May; 26(5):783-784. PubMed ID: 38417064
[No Abstract] [Full Text] [Related]
11. Characteristic features of stem cells in glioblastomas: from cellular biology to genetics.
Knights MJ; Kyle S; Ismail A
Brain Pathol; 2012 Sep; 22(5):592-606. PubMed ID: 22303870
[TBL] [Abstract][Full Text] [Related]
12. Connect four with glioblastoma stem cell factors.
Gronych J; Pfister SM; Jones DT
Cell; 2014 Apr; 157(3):525-7. PubMed ID: 24766799
[TBL] [Abstract][Full Text] [Related]
13. Metabolic heterogeneity and adaptability in brain tumors.
Badr CE; Silver DJ; Siebzehnrubl FA; Deleyrolle LP
Cell Mol Life Sci; 2020 Dec; 77(24):5101-5119. PubMed ID: 32506168
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cells on demand.
Nawy T
Nat Methods; 2014 Jul; 11(7):715. PubMed ID: 25110783
[No Abstract] [Full Text] [Related]
15. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.
Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y
Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260
[TBL] [Abstract][Full Text] [Related]
16. [Cancer stem cells in glioblastoma].
Virolle T
Bull Cancer; 2017 Dec; 104(12):1075-1079. PubMed ID: 29153545
[No Abstract] [Full Text] [Related]
17. Evolution-driven crosstalk between glioblastoma and the tumor microenvironment.
Wu L; Chai R; Lin Z; Wu R; Yao D; Jiang T; Wang Q
Cancer Biol Med; 2023 Mar; 20(5):319-24. PubMed ID: 36880534
[No Abstract] [Full Text] [Related]
18. Angiogenesis and hypoxia in glioblastoma: a focus on cancer stem cells.
Mongiardi MP
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):878-83. PubMed ID: 23131159
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments.
Shen Y; Grisdale CJ; Islam SA; Bose P; Lever J; Zhao EY; Grinshtein N; Ma Y; Mungall AJ; Moore RA; Lun X; Senger DL; Robbins SM; Wang AY; MacIsaac JL; Kobor MS; Luchman HA; Weiss S; Chan JA; Blough MD; Kaplan DR; Cairncross JG; Marra MA; Jones SJM
Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19098-19108. PubMed ID: 31471491
[TBL] [Abstract][Full Text] [Related]
20. Down-expression of miR-154 suppresses tumourigenesis in CD133(+) glioblastoma stem cells.
Yang L; Yan Z; Wang Y; Ma W; Li C
Cell Biochem Funct; 2016 Aug; 34(6):404-13. PubMed ID: 27338789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
